文献
J-GLOBAL ID:201802216859204842
整理番号:18A0336916
オレキシン-2選択的受容体きっ抗薬の研究:二重オレキシン受容体アンタゴニストをもたらす構造変化【Powered by NICT】
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
著者 (21件):
Skudlarek Jason W.
(Department of Medicinal Chemistry, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
DiMarco Christina N.
(Department of Medicinal Chemistry, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Babaoglu Kerim
(Department of Chemical Capabilities & Screening, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Roecker Anthony J.
(Department of Medicinal Chemistry, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Bruno Joseph G.
(Department of In Vitro Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Pausch Mark A.
(Department of In Vitro Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
O’Brien Julie A.
(Department of In Vitro Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Cabalu Tamara D.
(Department of Drug Metabolism, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Stevens Joanne
(Department of In Vivo Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Brunner Joseph
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Tannenbaum Pamela L.
(Department of In Vivo Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Wuelfing W. Peter
(Discovery Pharmaceutical Sciences, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Garson Susan L.
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Fox Steven V.
(Department of In Vivo Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Savitz Alan T.
(Department of In Vivo Pharmacology, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Harrell Charles M.
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Gotter Anthony L.
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Winrow Christopher J.
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Renger John J.
(Department of Neuroscience, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
,
Kuduk Scott D.
(Novira Therapeutics, Inc., a part of Janssen Pharmaceuticals, Doylestown, PA 18902, USA)
,
Coleman Paul J.
(Department of Medicinal Chemistry, MRL, Merck & Co., Inc., West Point, PA 19486, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
27
号:
6
ページ:
1364-1370
発行年:
2017年
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)